Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Temporomandibular Disorder (TMD) Diagnostic Concordance Between Physiotherapist and Surgeon (TMD)

Improving Access and Care Quality for Temporomandibular Disorder Patients - a Prospective Study to Examine Diagnostic Concordance Between Advanced-practice Physical Therapist and Oral and Maxillofacial Surgeon

Jaw disorders is the leading cause in facial pain, affecting many people in the world. Despite many patients finding relief from conservative treatment, many get referred to the surgeon for an evaluation. In order to improve access to care and reduce wait times, a new advanced practice physiotherapist-led triage model is being studied.

Descripción general del estudio

Descripción detallada

Temporomandibular disorders (TMD), involving the temporomandibular joint and masticatory muscles, are the leading cause of orofacial pain, affecting approximately 5-12% of the global population and generating an estimated $4 billion in annual healthcare costs. While 50-90% of individuals experience symptom relief through non-surgical interventions, fewer than 10% ultimately require surgical treatment. For patients who do not respond to conservative management, referral to a medical specialist is typically necessary to guide further care. In Canada, however, high demand for specialized services results in prolonged wait times. At the McGill Oral and Maxillofacial Surgery (OMFS) Division, patients can wait more than six months for an initial consultation and over a year for a surgical procedure. When accounting for additional delays related to diagnostic imaging and prior referrals, total wait times may exceed two years. These delays can have deleterious consequences, including worsening pain, increased functional disability, and a significant decline in quality of life for patients awaiting timely interventions. Above all, in the absence of a structured triage process, many patients are prematurely referred to surgical services, often before exhausting appropriate non-surgical options. This contributes to unnecessary delays in care, increased healthcare costs, and excessive demand on already overburdened speciality clinics.

The implementation of innovative care models led by advanced practice physiotherapists (APPTs) offers a promising solution. APPTs are highly trained health professionals with advanced competencies in musculoskeletal assessment, differential diagnosis, and evidence-based management, with the ability, depending on regulated scope of practice, to independently recommend investigations, initiate treatment plans, and make referrals when necessary. Advanced practice physiotherapy (APPT) models of care have been successfully deployed in various specialized care settings-such as orthopaedics, neurosurgery and rheumatology, where they have improved patient flow, reduced wait times, and maintained or improved patients' clinical outcomes. In these contexts, APPTs function as a first-contact autonomous practitioners, managing a substantial proportion of MSKD cases that would otherwise be directed to physicians or surgeons.

By integrating APPTs into the triage pathway for TMJ referrals, patients could be more effectively directed toward appropriate non-surgical care, such as physiotherapy, education, and self-management strategies, when surgical intervention is not warranted. This approach would help preserve the Oral and Maxillofacial Surgery department resources for patients with conditions that truly require surgical expertise. While APPT models have been successfully implemented and evaluated in various musculoskeletal care settings, no studies to date have described or assessed the implementation of such a model specifically for the management and triage of TMDs. This represents a significant gap in the literature and an important opportunity to explore the potential benefits of APPT-led care in improving access and efficiency in specialized orofacial pain services.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

70

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Philip Lu
  • Número de teléfono: 604-562-0028
  • Correo electrónico: philip.lu@mcgill.ca

Ubicaciones de estudio

    • Quebec
      • Montreal, Quebec, Canadá
        • Montreal General Hospital
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Referred for new consultation at the MUHC TMJ clinic for temporomandibular joint (TMJ) pain or dysfunction
  • Residents of the province of Quebec and benefiaries of provincial universal health insurance coverage (Régie de l'Assurance Maladie du Québec - RAMQ)
  • Be able to understand and communicate in either French of English
  • Be legally capable of providing informed consent

Exclusion Criteria:

  • Presenting for a follow-up visit (i.e., not a new consultation)
  • Have undergone TMJ surgery within the past six months
  • Referred directly from a recognized orofacial pain dentist or oral medicine specialist
  • Referred for acute TMJ trauma requiring urgent management (e.g., fractures, dislocations)
  • Present with complex or multi-system pathology that could confound the diagnostic process and are not related to TMD

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Diagnóstico
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Physiotherapy Assessment

This is a non-randomized study as each participant will undergo two independent clinical assessments: one performed by the advanced-practice physical therapist (APPT) and one by the oral and maxillofacial surgeon (OMFS) and/or resident under supervision.

For logistical and feasibility reasons, the APPT will conduct the first assessment. After a brief rest period, the participant will be seen by the OMFS. Both clinicians will be blinded to each other's findings, and participants will be explicitly instructed not to share any information from the first assessment during the second.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)
Periodo de tiempo: Day 1
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)
Day 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
9-item Visit-Specific Satisfaction Questionnaire (VSQ-9)
Periodo de tiempo: Day 1
9-item Visit-Specific Satisfaction Questionnaire (VSQ-9)
Day 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de septiembre de 2026

Finalización primaria (Estimado)

1 de abril de 2027

Finalización del estudio (Estimado)

1 de junio de 2027

Fechas de registro del estudio

Enviado por primera vez

10 de abril de 2026

Primero enviado que cumplió con los criterios de control de calidad

28 de abril de 2026

Publicado por primera vez (Actual)

1 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de mayo de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

28 de abril de 2026

Última verificación

1 de abril de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir